BRCA1 Functions as a Novel Transcriptional Cofactor in HIV-1 Infection

Simple item page
dc.contributor.advisorKehn-Hall, Kylene
dc.contributor.authorGüendel Sánchez, Irene
dc.creatorGüendel Sánchez, Irene
dc.date2014-05
dc.date.accessioned2014-09-23T18:54:52Z
dc.date.available2015-05-27T04:13:50Z
dc.date.issued2014-09-23
dc.description.abstractViruses have naturally evolved elegant strategies to manipulate host cellular machinery, including ways to hijack cellular DNA repair proteins to aid in their own replication. Retroviruses induce DNA damage through integration of their genome into the host DNA. DNA damage signaling proteins including ATR, ATM and BRCA1 contribute to multiple steps in the HIV-1 life cycle, including integration and Vpr- induced G2/M arrest. However, there have been no studies to date regarding the role of BRCA1 on HIV-1 transcription. Size-exclusion chromatography experiments showed that BRCA1 eluted in the same fraction as other cellular proteins involved in HIV-1 transcription, including Cyclin T1 and Cdk9. BRCA1 was found to be important for viral transcription as cells that lack BRCA1 displayed severely reduced HIV-1 Tat-dependent transcription, and overexpression or selective depletion resulted in enhanced or decreased transcription. Moreover, small molecule inhibition of BRCA1 phosphorylation effector kinases, ATR and ATM, decreased Tat-dependent transcription, whereas a Chk2 inhibitor showed no effect. Furthermore, treatment with curcumin and an ATM inhibitor decreased BRCA1 LTR occupancy. In addition, Tat was found to associate with BRCA1. These results suggest that HIV-1 infection upregulates expression of BRCA1 and may utilize its transcriptional cofactor function for efficient transcription. The presence of BRCA1 at the HIV-1 promoter highlights a novel function of the multifaceted protein in HIV-1 infection. The BRCA1 pathway or enzymes that phosphorylate BRCA1 could potentially be used as complementary host-based treatment for combined antiretroviral therapy, as there are multiple potent ATM inhibitors in development as chemotherapeutics.
dc.description.noteThis work was embargoed by the author and will not be available until May 2015.
dc.identifier.urihttps://hdl.handle.net/1920/8945
dc.language.isoen_US
dc.rightsCopyright 2014 Irene Güendel Sánchez
dc.subjectHIV-1
dc.titleBRCA1 Functions as a Novel Transcriptional Cofactor in HIV-1 Infection
dc.typeDissertation
thesis.degree.disciplineBiosciences
thesis.degree.grantorGeorge Mason University
thesis.degree.levelDoctoral
thesis.degree.namePhD in Biosciences

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Guendel_gmu_0883E_10617.pdf
Size:
1.8 MB
Format:
Adobe Portable Document Format
Description:
Dissertation
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

College of Science